LETAIRIS Side Effects

6979566-3 | Cardiac Failure Congestive
on Sep 07, 2010 Male patient from UNITED STATES , weighting 214.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive. Letairis dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), COUMADIN (View Coumadin Review and Coumadin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), COREG (View Coreg Review and Coreg Label ), COZAAR (View Cozaar Review and Cozaar Label ), PRAZOSIN HCL (View Prazosin Hcl Review and Prazosin Hcl Label ). Patient was hospitalized.

6979509-2 | Catheterisation Cardiac
Patient was taking Letairis (View Usage). Patient had the following side effects: catheterisation cardiac on Sep 07, 2010 from UNITED STATES Additional patient health information: Male patient , 15 years of age, weighting 155.1 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with ADCIRCA (View Adcirca Review and Adcirca Label ), TYVASO (View Tyvaso Review and Tyvaso Label ), NORVASC (View Norvasc Review and Norvasc Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6979489-X |
Adverse event was reported on Sep 08, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 90 years of age, weighting 140.1 lb, . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LASIX (View Lasix Review and Lasix Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), DIOVAN (View Diovan Review and Diovan Label ), REQUIP (View Requip Review and Requip Label ), METHADONE (View Methadone Review and Methadone Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

6978931-8 |
on Sep 07, 2010 Female patient from UNITED STATES , weighting 138.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with PEPCID (View Pepcid Review and Pepcid Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), BENADRYL (View Benadryl Review and Benadryl Label ), REYATAZ (View Reyataz Review and Reyataz Label ), LASIX (View Lasix Review and Lasix Label ), TRICOR (View Tricor Review and Tricor Label ), NORVIR (View Norvir Review and Norvir Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ).


6978801-5 |
on Sep 09, 2010 Female patient from UNITED STATES , 64 years of age, weighting 158.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with TYVASO (View Tyvaso Review and Tyvaso Label ), REVATIO (View Revatio Review and Revatio Label ), OXYGEN (View Oxygen Review and Oxygen Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), NORVASC (View Norvasc Review and Norvasc Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

6977484-8 | Rectal Haemorrhage
Patient was taking Letairis (View Usage). After Letairis was administered, patient had the following side effects: rectal haemorrhage on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 240.2 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with ADCIRCA (View Adcirca Review and Adcirca Label ), ANUSOL HC (View Anusol Hc Review and Anusol Hc Label ), DARVOCET (View Darvocet Review and Darvocet Label ), ZAROXOLYN (View Zaroxolyn Review and Zaroxolyn Label ), LASIX (View Lasix Review and Lasix Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6977468-X |
Adverse event was reported on Sep 08, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 73 years of age, weighting 189.1 lb, . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), COMBIVENT (View Combivent Review and Combivent Label ), ZOLOFT (View Zoloft Review and Zoloft Label ).

6974449-7 |
on Sep 07, 2010 Male patient from UNITED STATES , weighting 145.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with PROTONIX (View Protonix Review and Protonix Label ), XANAX (View Xanax Review and Xanax Label ), PAXIL (View Paxil Review and Paxil Label ), LASIX (View Lasix Review and Lasix Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), NICOTINE (View Nicotine Review and Nicotine Label ), NOVOLOG (View Novolog Review and Novolog Label ).

6974001-3 | Pericardial Effusion, Pleural Effusion
on Sep 03, 2010 Male patient from UNITED STATES , 74 years of age, weighting 227.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). After Letairis was administered, patient had the following side effects: pericardial effusion, pleural effusion. Letairis dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), COUMADIN (View Coumadin Review and Coumadin Label ), IMDUR (View Imdur Review and Imdur Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), COZAAR (View Cozaar Review and Cozaar Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

6973987-0 | Cerebrovascular Accident, Hypotension
Patient was taking Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, hypotension on Sep 02, 2010 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 174.2 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), TRETINOIN (View Tretinoin Review and Tretinoin Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6973406-4 |
Adverse event was reported on Sep 03, 2010 by a Male patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 238.2 lb, . During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ISOSORBIDE (View Isosorbide Review and Isosorbide Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ).

6973263-6 | Lung Cancer Metastatic
on Sep 01, 2010 Female patient from UNITED STATES , weighting 163.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). After Letairis was administered, patient had the following side effects: lung cancer metastatic. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LASIX (View Lasix Review and Lasix Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), NORVASC (View Norvasc Review and Norvasc Label ), MIRALAX (View Miralax Review and Miralax Label ), VICODIN (View Vicodin Review and Vicodin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FOSAMAX (View Fosamax Review and Fosamax Label ).

6973233-8 | Renal Failure
on Aug 20, 2010 Male patient from UNITED STATES , weighting 300.3 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure. Letairis dosage: . During the same period patient was treated with PRINIVIL (View Prinivil Review and Prinivil Label ), ZOCOR (View Zocor Review and Zocor Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), LASIX (View Lasix Review and Lasix Label ), NORVASC (View Norvasc Review and Norvasc Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LANTUS (View Lantus Review and Lantus Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ). Patient was hospitalized.

6971873-3 | Intestinal Obstruction
Patient was taking Letairis (View Usage). Patient had the following side effects: intestinal obstruction on Sep 02, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 165.1 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6971863-0 | Pneumonia
Adverse event was reported on Sep 07, 2010 by a Male patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 210.2 lb, After Letairis was administered, patient had the following side effects: pneumonia (What is pneumonia?). During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), TYVASO (View Tyvaso Review and Tyvaso Label ), OXYGEN (View Oxygen Review and Oxygen Label ), PLAVIX (View Plavix Review and Plavix Label ), LASIX (View Lasix Review and Lasix Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), RANEXA (View Ranexa Review and Ranexa Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

6971040-3 |
on Sep 03, 2010 Female patient from UNITED STATES , weighting 120.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6970937-8 |
on Sep 02, 2010 Male patient from UNITED STATES , weighting 185.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), ALLEGRA (View Allegra Review and Allegra Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FEXOFENADINE HCL (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ).

6970259-5 | Sickle Cell Anaemia With Crisis
Patient was taking Letairis (View Usage). After Letairis was administered, patient had the following side effects: sickle cell anaemia with crisis on Sep 01, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 180.2 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LORTAB (View Lortab Review and Lortab Label ), HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), MOTRIN IB (View Motrin Ib Review and Motrin Ib Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

6969412-6 | Dyspnoea, Respiratory Failure, Scleroderma
Adverse event was reported on Sep 02, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 145.1 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, respiratory failure, scleroderma (What is scleroderma?). During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM (View Calcium Review and Calcium Label ), ERGOCALCIFER (View Ergocalcifer Review and Ergocalcifer Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

6969097-9 | Lung Disorder
on Aug 31, 2010 Female patient from UNITED STATES , weighting 132.3 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient had the following side effects: lung disorder. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), MYFORTIC (View Myfortic Review and Myfortic Label ), IMURAN (View Imuran Review and Imuran Label ), NEXIUM (View Nexium Review and Nexium Label ), KLOR CON (View Klor-con Review and Klor-con Label ), COLACE (View Colace Review and Colace Label ). Patient was hospitalized.

6968427-1 |
on Aug 30, 2010 Female patient from UNITED STATES , weighting 100.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), NABUMETONE (View Nabumetone Review and Nabumetone Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), LASIX (View Lasix Review and Lasix Label ), PROVENTIL (View Proventil Review and Proventil Label ), NASONEX (View Nasonex Review and Nasonex Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), HYDRALAZINE (View Hydralazine Review and Hydralazine Label ).

6961816-0 | Dyspnoea, Scleroderma
Patient was taking Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, scleroderma (What is scleroderma?) on Aug 27, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 126.1 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM (View Calcium Review and Calcium Label ), ERGOCALCIFER (View Ergocalcifer Review and Ergocalcifer Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

6961580-5 |
Adverse event was reported on Aug 25, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 105.1 lb, . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN (View Metformin Review and Metformin Label ).

6960917-0 | Catheterisation Cardiac
on Aug 27, 2010 Female patient from UNITED STATES , 69 years of age, weighting 150.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). After Letairis was administered, patient had the following side effects: catheterisation cardiac. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), TRETROSTINIL (View Tretrostinil Review and Tretrostinil Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

6960633-5 | Bronchitis Viral
on Aug 24, 2010 Female patient from UNITED STATES , 74 years of age, weighting 163.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis viral. Letairis dosage: . During the same period patient was treated with CARTIA XT (View Cartia Xt Review and Cartia Xt Label ), LIPITOR (View Lipitor Review and Lipitor Label ), COUMADIN (View Coumadin Review and Coumadin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), ATROVENT (View Atrovent Review and Atrovent Label ). Patient was hospitalized.

6960504-4 | Pericardial Effusion, Pleural Effusion
Patient was taking Letairis (View Usage). Patient had the following side effects: pericardial effusion, pleural effusion on Aug 26, 2010 from UNITED STATES Additional patient health information: Female patient , 76 years of age, weighting 123.1 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), TYVASO (View Tyvaso Review and Tyvaso Label ), ADCIRCA (View Adcirca Review and Adcirca Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), XALATAN (View Xalatan Review and Xalatan Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), CALTRATE (View Caltrate Review and Caltrate Label ). Patient was hospitalized.

6958266-X | Cerebrovascular Accident
Adverse event was reported on Aug 25, 2010 by a Male patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 168.2 lb, After Letairis was administered, patient had the following side effects: cerebrovascular accident. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6956844-5 | Chest Pain, Pneumonia
on Aug 26, 2010 Female patient from UNITED STATES , 60 years of age, weighting 185.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), pneumonia (What is pneumonia?). Letairis dosage: . During the same period patient was treated with COREG (View Coreg Review and Coreg Label ), LASIX (View Lasix Review and Lasix Label ), VASOTEC (View Vasotec Review and Vasotec Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), JANUVIA (View Januvia Review and Januvia Label ), TRANXENE (View Tranxene Review and Tranxene Label ), NEXIUM (View Nexium Review and Nexium Label ), KLOR CON (View Klor-con Review and Klor-con Label ). Patient was hospitalized.

6946155-6 |
on Aug 23, 2010 Female patient from UNITED STATES , weighting 157.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with PULMICORT (View Pulmicort Review and Pulmicort Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COUMADIN (View Coumadin Review and Coumadin Label ), FLOMAX (View Flomax Review and Flomax Label ), TRENTAL (View Trental Review and Trental Label ).

6943469-0 | Cerebrovascular Accident
Patient was taking Letairis (View Usage). After Letairis was administered, patient had the following side effects: cerebrovascular accident on Aug 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 220.2 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with BUPROPION (View Bupropion Review and Bupropion Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), LOVENOX (View Lovenox Review and Lovenox Label ), REVLIMID (View Revlimid Review and Revlimid Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ). Patient was hospitalized.

6943415-X | Anaemia, Blood Count Abnormal, Chest Pain
Adverse event was reported on Aug 18, 2010 by a Male patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 150.4 lb, Patient experienced the following unwanted or unexpected effects: anaemia, blood count abnormal, chest pain (What is chest pain?). During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), BENICAR (View Benicar Review and Benicar Label ), CARDIZEM LA (View Cardizem La Review and Cardizem La Label ), PAXIL (View Paxil Review and Paxil Label ), GLUCOTROL (View Glucotrol Review and Glucotrol Label ), IMDUR (View Imdur Review and Imdur Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), AVODART (View Avodart Review and Avodart Label ). Patient was hospitalized.

6941615-6 | Cerebrovascular Accident
on Aug 18, 2010 Male patient from UNITED STATES , weighting 172.0 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient had the following side effects: cerebrovascular accident. Letairis dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6941611-9 | Gastrooesophageal Reflux Disease, Oesophageal Hypomotility
on Aug 23, 2010 Female patient from UNITED STATES , weighting 118.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). After Letairis was administered, patient had the following side effects: gastrooesophageal reflux disease, oesophageal hypomotility. Letairis dosage: . During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASTELIN (View Astelin Review and Astelin Label ), HUMIRA (View Humira Review and Humira Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), EVISTA (View Evista Review and Evista Label ). Patient was hospitalized.

6941064-0 | Hypoxia
Patient was taking Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: hypoxia on Aug 19, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 240.2 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), WARFARIN (View Warfarin Review and Warfarin Label ), RANEXA (View Ranexa Review and Ranexa Label ), MAVIK (View Mavik Review and Mavik Label ), HYTRIN (View Hytrin Review and Hytrin Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

6940830-5 | Catheterisation Cardiac
Adverse event was reported on Aug 18, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 51 years of age, weighting 140.1 lb, Patient had the following side effects: catheterisation cardiac. During the same period patient was treated with FLOLAN (View Flolan Review and Flolan Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), PERCOCET (View Percocet Review and Percocet Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PROTONIX (View Protonix Review and Protonix Label ). Patient was hospitalized.

6940828-7 | Respiratory Disorder
on Aug 20, 2010 Female patient from UNITED STATES , weighting 264.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). After Letairis was administered, patient had the following side effects: respiratory disorder. Letairis dosage: . During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), REVATIO (View Revatio Review and Revatio Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LASIX (View Lasix Review and Lasix Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), VENTOLIN (View Ventolin Review and Ventolin Label ). Patient was hospitalized.

6940813-5 |
on Aug 19, 2010 Female patient from UNITED STATES , 64 years of age, weighting 158.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with TYVASO (View Tyvaso Review and Tyvaso Label ), REVATIO (View Revatio Review and Revatio Label ), OXYGEN (View Oxygen Review and Oxygen Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), NORVASC (View Norvasc Review and Norvasc Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

6940543-X | Gastroenteritis
Patient was taking Letairis (View Usage). Patient had the following side effects: gastroenteritis (What is gastroenteritis?) on Aug 20, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 270.2 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with ADCIRCA (View Adcirca Review and Adcirca Label ), OXYGEN (View Oxygen Review and Oxygen Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), BENICAR HCT (View Benicar Hct Review and Benicar Hct Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), PROMETHAZINE W/ CODEINE (View Promethazine W/ Codeine Review and Promethazine W/ Codeine Label ). Patient was hospitalized.

6939466-1 | Chest Pain, Dyspnoea
Adverse event was reported on Aug 16, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 161.1 lb, After Letairis was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), LASIX (View Lasix Review and Lasix Label ), XOPENEX (View Xopenex Review and Xopenex Label ), FLOVENT (View Flovent Review and Flovent Label ), VERAMYST (View Veramyst Review and Veramyst Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), NIACIN (View Niacin Review and Niacin Label ). Patient was hospitalized.

6939303-5 |
on Aug 18, 2010 Male patient from UNITED STATES , 73 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LASIX (View Lasix Review and Lasix Label ), PROCRIT (View Procrit Review and Procrit Label ), SODIUM BICARB (View Sodium Bicarb Review and Sodium Bicarb Label ).

6938618-4 | Pneumonia
on Aug 18, 2010 Male patient from UNITED STATES , weighting 210.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), TYVASO (View Tyvaso Review and Tyvaso Label ), OXYGEN (View Oxygen Review and Oxygen Label ), PLAVIX (View Plavix Review and Plavix Label ), LASIX (View Lasix Review and Lasix Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), RANEXA (View Ranexa Review and Ranexa Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

6938609-3 | Thrombosis
Patient was taking Letairis (View Usage). After Letairis was administered, patient had the following side effects: thrombosis on Aug 18, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 236.2 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ZESTRIL (View Zestril Review and Zestril Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), ZOCOR (View Zocor Review and Zocor Label ), LUMIGAN (View Lumigan Review and Lumigan Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ). Patient was hospitalized.

6938605-6 | Myopathy
Adverse event was reported on Aug 18, 2010 by a Male patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 204.2 lb, Patient experienced the following unwanted or unexpected effects: myopathy. During the same period patient was treated with VIAGRA (View Viagra Review and Viagra Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LASIX (View Lasix Review and Lasix Label ), ZOCOR (View Zocor Review and Zocor Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ALLEGRA (View Allegra Review and Allegra Label ), FLONASE (View Flonase Review and Flonase Label ), MUCINEX (View Mucinex Review and Mucinex Label ). Patient was hospitalized.

6938604-4 | Lung Neoplasm Malignant
on Aug 18, 2010 Male patient from UNITED STATES , weighting 155.9 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient had the following side effects: lung neoplasm malignant. Letairis dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), DUONEB (View Duoneb Review and Duoneb Label ), SEREVENT (View Serevent Review and Serevent Label ), WELLBUTRIN XL (View Wellbutrin Xl Review and Wellbutrin Xl Label ), XANAX (View Xanax Review and Xanax Label ), ARICEPT (View Aricept Review and Aricept Label ). Patient was hospitalized.

6938577-4 | Respiratory Failure, Sepsis, Shock
on Aug 19, 2010 Female patient from UNITED STATES , weighting 212.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). After Letairis was administered, patient had the following side effects: respiratory failure, sepsis (What is sepsis?), shock. Letairis dosage: . During the same period patient was treated with HYZAAR (View Hyzaar Review and Hyzaar Label ), INNOPRAN XL (View Innopran Xl Review and Innopran Xl Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6937628-0 | Liver Disorder
Patient was taking Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder on Aug 09, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 198.2 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with VENTAVIS (View Ventavis Review and Ventavis Label ), REVATIO (View Revatio Review and Revatio Label ), OXYGEN (View Oxygen Review and Oxygen Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), LASIX (View Lasix Review and Lasix Label ), XOPENEX (View Xopenex Review and Xopenex Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ). Patient was hospitalized.

6937420-7 |
Adverse event was reported on Aug 16, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 155.1 lb, . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), REQUIP (View Requip Review and Requip Label ), LASIX (View Lasix Review and Lasix Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ).

6936899-4 | Arthropathy, Ileus
on Aug 18, 2010 Female patient from UNITED STATES , weighting 232.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). After Letairis was administered, patient had the following side effects: arthropathy, ileus. Letairis dosage: . During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), LASIX (View Lasix Review and Lasix Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SAPHRIS (View Saphris Review and Saphris Label ), MIDODRINE HYDROCHLORIDE (View Midodrine Hydrochloride Review and Midodrine Hydrochloride Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ). Patient was hospitalized.

6934693-1 |
on Aug 16, 2010 Female patient from UNITED STATES , weighting 150.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LASIX (View Lasix Review and Lasix Label ), COREG (View Coreg Review and Coreg Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), PERCOCET (View Percocet Review and Percocet Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ).

6934689-X | Chest Pain, Dyspnoea, Oedema
Patient was taking Letairis (View Usage). Patient had the following side effects: chest pain (What is chest pain?), dyspnoea, oedema on Aug 16, 2010 from UNITED STATES Additional patient health information: Female patient , 87 years of age, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . Patient was hospitalized.